CRISPR Therapeutics 주식 (NASDAQ: CRSP)

에 대한 최신 뉴스 CRISPR Therapeutics (NASDAQ:CRSP) 주식

CRISPR Therapeutics

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Cathie Wood Bets On Baidu As Chinese AI Buzz Intensifies, Ark Loads Up On $12.4 Million Worth Of Stock

Equities

News

Markets

Tech

ETFs

AMZN

ARKF

ARKK

ARKQ

ARKW

BEAM

COIN

CRSP

MELI

PATH

RBLX

RPTX

2025년 4월 4일 금요일에 캐시 우드가 이끄는 아크 인베스트는 코인베이스 글로벌(NASDAQ:COIN), 아마존닷컴(NASDAQ:AMZN), 크리스퍼 테라퓨틱스 AG(NGM:CRSP), 빔 테라퓨틱스(NASDAQ:BEAM), 유아이패스(NYSE:PATH), 로블록스(NYSE:RBLX), 메르카도리브레(NASDAQ:MELI), 그리고 리페어 테라퓨틱스(NASDAQ:RPTX)를 포함한 여러 저명한 기업에 대해 상당한 거래를 했다.

아크 인베스트, 아마존 주식이 20% 이상 하락한 가운데 매수: 유아이패스, 로블록스 매각

Ark Invest's Cathie Wood Says Belief In Bitcoin's $1.5 Million Price Target By 2030 Has Grown

$BTC

DKNG

화요일(11일) 캐시 우드의 아크 인베스트는 템퍼스AI(NASDAQ:TEM), 블록(NYSE:XYZ), 드래프트킹스(NASDAQ:DKNG)과 관련해 주목할

아크 인베스트: 템퍼스AI에 지속 투자, 기술주 급락 후 블록 매도 등

Uber Weride

Mid Cap

Movers

Trading Ideas

AXSM

MKGAF

MKKGY

NVDA

RXRX

SWTX

TEVA

VNET

이들 10개 대형주는 지난 주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 위라이드(NASDAQ:WRD)의 주식이 97.62% 급등했다. 이는 엔비디아(NASDAQ:NVDA)가 13F 제출을 통해 174만 주의 지분을 보유하고 있다고 공개한 후 발생한 일이다.

위라이드, 크리스퍼 및 진DX 등 지난주 최대 상승한 10개의 중형주 (2월 10일-2월 14일)

CRISPR Therapeutics AG

One poster recently surprised Reddit&#8217;s <a href="https://www.reddit.com/r/legaladvice/comments/1kr6ngy/won_15m_judgement_28_years_ago_and_just_found_out/">r/legaladvice</a> community after discovering that their father had been awarded a $1.5 million court judgment nearly three decades ago—and never knew about it.
The post, titled &#8220;Won $1.5M judgement 28 years ago and just found out yesterday,&#8221; got a lot of attention after the person explained how they came across the information by accident. "Yesterday, while searching the Bronx County court records for my father in a separate matter, we found record of a workers&#8217; comp case filed on his behalf in &#8217;97," the person wrote.
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
</ul>
<h2 class="wp-block-heading">&#8216;Father Had No Idea&#8217;</h2>
According to the post, the poster&#8217;s father lost three fingers in a factory accident in 1996. The family had recently immigrated to the U.S. at the time, and he spoke no English. "The issue is my father had no idea that this lawsuit was even filed," the poster wrote.&nbsp;
Though he sat for a deposition, he was allegedly told by the company that nothing would come of the case. The family then moved, changed phone numbers, and assumed that was the end of it.
They later added, &#8220;It feels to me like things weren't handled correctly and I want to make sure he is compensated appropriately as our lives could have been much different had he received this money.&#8221;
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
Expired Judgment?
Most commenters were quick to point out that New York judgments typically expire after 20 years unless they are renewed.
"In New York, a judgment is deemed unenforceable after 20 years. If nothing was done to renew the judgment, it's dead now," wrote one commenter, who identified themselves as a lawyer.
However, several people noted that exceptions exist in cases involving fraud or malpractice. &#8220;Sometimes the law allows for an extension of deadlines where there&#8217;s fraud or another good reason,&#8221; one person pointed out.
Another added, &#8220;If the lawyer collected on the judgment, then a claim could exist against the lawyer for your father&#8217;s share.&#8221;
But, as someone said, &#8220;I'd be afraid someone filed and collected on his behalf without ever telling him, maybe even someone at the company.&#8221;
See Also: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
<h2 class="wp-block-heading">What To Do Now</h2>
Redditors with legal experience weighed in with suggestions on what steps to take. First on the list: track down the original attorney or firm. Even if they have since left the industry, they may still have records or owe a duty to account for any funds.
"Contacting the attorney would be a very helpful start," wrote one poster familiar with bar association procedures. "There's a decent chance they still have a hard copy of the files in a box somewhere."
Another crucial step? Search the New York State Comptroller's unclaimed funds database. Multiple commenters said they had found <a href="https://www.benzinga.com/money/how-to-claim-unclaimed-bitcoin">forgotten funds</a> owed to them through the site. One even commented, "I just made my rent this month" after finding a claim in their name.
And if it turns out the money was never paid? The family may have a legal malpractice case if the attorney failed to inform them of the judgment or disbursed funds improperly.
<h2 class="wp-block-heading">Might Not Be the Windfall It Sounds Like</h2>
A few commenters speculated that the case might have involved subrogation, where the <a href="https://www.benzinga.com/money/workers-comp-calculator">workers&#8217; compensation</a> insurer sues a third party – like the machine manufacturer – on the injured worker&#8217;s behalf. In that case, most or all of the money could have gone to reimburse the insurer.
Still, the original poster is determined to pursue answers: "We'll be contacting the original lawyer and a few other avenues mentioned here," they wrote.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

Personal Finance

They 'Just Found Out Yesterday' About Winning A '$1.5M Judgment 28 Years Ago.' Now They're Asking: What Do I Even Do With This?

It seems like Mark Cuban has no patience for how America pays for healthcare. In a recent <a href="https://www.youtube.com/watch?v=vwsQKuWNgXU">appearance</a> at the Stanford University Department of Medicine, he laid out exactly how he thinks insurance companies are rigging the system—and leaving hospitals and doctors holding the bag.
<h2 class="wp-block-heading">Insurance Plans Work For Insurers, Not Providers</h2>
According to Cuban, it all starts with how <a href="https://www.benzinga.com/25/05/45458113/mark-cuban-blasts-health-insurance-companies-as-the-worst-of-the-worst-says-it-should-be-criminal-to-charge-5k-deductibles-to-people-making-25k">insurance companies</a> design their plans. Every year, they tweak things so premiums stay low, but out-of-pocket costs quietly increase. This pushes patients toward high-deductible health plans that look affordable on paper but become a disaster when someone actually gets sick.
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
</ul>
&#8220;Depending on what&#8217;s going on in the economy, those patients, particularly as they skew a little younger or a little poorer, take low-premium, <a href="https://www.benzinga.com/news/25/02/43985233/mark-cuban-calls-deductibles-the-biggest-problem-in-healthcare-system-needs-to-be-redesigned">high-deductible plans</a>,&#8221; Cuban said. &#8220;Which is good for the insurance companies. You know who it&#8217;s not good for? You guys.&#8221;
By &#8220;you guys,&#8221; Cuban meant the doctors and hospitals who end up taking on the financial risk. If a patient can't pay the deductible, the insurer already got its money, but the provider hasn't. &#8220;You take on all that credit risk,&#8221; Cuban explained. &#8220;And you also take on the brand and reputational risk&#8230; Did you cause the problem? No.&#8221;
<h2 class="wp-block-heading">Doctors Pay Twice: Financially And Emotionally</h2>
Cuban pointed out that many patients are confused by their bills and blame the hospital, not the insurer. &#8220;When everybody talks about the $400 billion in <a href="https://www.benzinga.com/news/25/04/44609989/it-feels-illegal-says-a-patient-after-hospital-forgave-all-their-medical-debt-anyone-dealing-with-medical-bills-should-look-into-this">unpaid medical debt</a>, who gets the blame? You do,&#8221; he said. &#8220;And when the patient&#8217;s angry and looking at all these medical bills, who gets the blame?&#8221;
Trending: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
He argued this creates a cascade of problems that go beyond money. Doctors feel rushed. Care feels transactional. And fewer people want to stay in the profession. Cuban said his goal is to bring simplicity and fairness back into the equation.
<h2 class="wp-block-heading">The Fix</h2>
One of Cuban&#8217;s solutions is direct contracting. Through his Cost Plus Wellness venture, he&#8217;s working with hospitals and doctors to create deals that <a href="https://www.benzinga.com/personal-finance/25/01/43083417/charlie-munger-said-he-and-warren-buffett-skip-insurance-and-all-rich-should-too-i-can-so-easily-rebuild-a-house-that-would-burn-down">skip insurance companies</a> altogether. &#8220;We go to Stanford and say, &#8216;We know what happens in the relationship between you and the big insurance company,'&#8221; he said. &#8220;Why don&#8217;t you give us a better price?&#8221;
He said most hospitals lose 3% to 5% fighting insurance companies for payment and have to hire massive administrative teams just to handle all the red tape. Meanwhile, they also deal with delays like pre-authorizations that often aren&#8217;t about medical necessity but about how long the insurance company can hold onto the money and earn interest.
See Also: <a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a>
<h2 class="wp-block-heading">Cuban's Message</h2>
Cuban&#8217;s pitch to providers is simple: stop relying on insurance companies and work directly with employers and patients. Publish your prices. Make it easier to understand care costs. And push back on systems that are designed to extract value from you, not create it.
&#8220;If you really want to change the system, you do have the power to do these things,&#8221; Cuban said.&nbsp;
Read Next: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a>
Image: Shutterstock

Mark Cuban Says Taking Low-Premium, High-Deductible Plans Is Great For Insurance Companies. 'You Know Who It's Not Good For? You Guys'

<a href="https://www.benzinga.com/news/large-cap/25/05/45612832/sap-capgemini-mistral-ai-unite-for-offering-solutions-for-regulated-industries">Mistral AI</a>, a Paris-based startup founded by former Meta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) researchers Guillaume Lample and Timothée Lacroix, is rapidly emerging as a key player in the open-source AI space, and it's doing so with <a href="https://www.benzinga.com/25/05/45609982/elon-musk-rival-ray-kurzweils-beyond-imagination-lands-100m-deal-as-tesla-nvidia-meta-race-toward-ai-powered-humanoid-robots">Meta</a>&#8216;s top talent.
The tech giant is contending with a major loss of talent within its AI division as the architects behind its flagship Llama models exit the company. According to<a href="https://www.businessinsider.com/meta-llama-ai-talent-mistral-2025-5"> Business Insider</a>, only three of the 14 researchers credited on the 2023 Llama paper remain employed at Meta.
Five of the Llama paper's co-authors have joined Mistral in the past 18 months, intensifying scrutiny around Meta's ability to retain top-tier AI personnel, Business Insider reports.
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
</ul>
<h2 class="wp-block-heading">Mistral AI's Rise Comes With $2B Backing And Open-Source Momentum</h2>
Backed by $2 billion in funding, Mistral AI is rapidly gaining ground as one of the most aggressive challengers in the open-source AI space. As reported by <a href="https://techcrunch.com/2025/05/23/what-is-mistral-ai-everything-to-know-about-the-openai-competitor/">TechCrunch</a>, the company is supported by premier venture firms including Andreessen Horowitz, Lightspeed Venture Partners, and Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>), all known for placing high-stakes bets on transformative technologies. Other notable backers include Bpifrance, Xavier Niel, Eric Schmidt, General Catalyst, and BNP Paribas, reflecting deep institutional and individual confidence in Mistral's long-term vision.
Founded in 2023, Mistral is building advanced open-weight AI models that directly compete with Meta's Llama family. Its approach appeals to developers seeking transparency and customization in contrast to the closed nature of proprietary systems. With former Meta researchers such as Marie-Anne Lachaux, Thibaut Lavril, and Baptiste Rozière now working alongside Mistral's founders, the company may lead the next wave of open-source innovation, Business Insider reports.
Trending: <a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a>&nbsp;
Meta's previous dominance in this space was largely defined by its decision to release Llama models with open access to their architecture and training data. According to Business Insider, that move helped validate open-weight large language models as viable alternatives to proprietary giants like OpenAI and Google. But with the original architects of Llama now working elsewhere, Meta's early lead is under pressure.
<h2 class="wp-block-heading">Meta Reshuffles Leadership As Behemoth Model Faces Delays</h2>
Meta's internal AI leadership is undergoing a shift as well. In April, longtime executive Joelle Pineau stepped away from her role leading the Fundamental AI Research group after eight years. Taking over the position is Robert Fergus, a FAIR co-founder and former DeepMind scientist, marking a return to Meta following a five-year stint at Google's AI lab, Business Insider says.
Separately,<a href="https://www.wsj.com/tech/ai/meta-is-delaying-the-rollout-of-its-flagship-ai-model-f4b105f7"> The Wall Street Journal</a> reported that Meta's largest AI model to date, dubbed Behemoth, has been delayed due to internal concerns over performance and direction. Meanwhile, Business Insider notes that developers are increasingly turning to faster-evolving alternatives such as Qwen and DeepSeek following the Llama 4 release.
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
Despite investing billions into AI infrastructure, Meta still lacks a model explicitly focused on reasoning tasks, such as multi-step problem-solving or tool use. According to Business Insider, competitors like OpenAI and Anthropic are moving quickly to prioritize those capabilities, and without that strategic leap, Meta's influence over the open-source ecosystem may continue to decline.
Of the 11 researchers who left Meta since the Llama paper's publication, most had been with the company for more than five years, according to LinkedIn profiles reviewed by Business Insider. Some departed as recently as February. Their exits mark a significant shift in Meta&#8217;s AI capabilities and raise questions about the company&#8217;s ability to maintain its leadership in the field.
Read Next: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a>
Image: Shutterstock

Meta's Llama AI Team Suffers Talent Exodus As Top Researchers Join $2B Mistral AI, Backed By Andreessen Horowitz And Salesforce

President Donald Trump&#8216;s approval remained unchanged this week, reflecting a continued pattern of <a href="https://www.benzinga.com/general/market-summary/25/05/45581555/growth-vs-value-expert-views-collide-on-the-impact-of-trumps-big-beautiful-bill" target="_blank" rel="noreferrer noopener">subdued public support in May</a>.
His second-term ratings have consistently trailed behind the average benchmarks, <a target="_blank" href="https://www.usatoday.com/story/news/politics/2025/05/30/president-trump-approval-rating-polls/83947020007/" rel="noreferrer noopener">reports </a>USA Today.
Trump ended April with an average job <a href="https://news.gallup.com/poll/659534/trump-first-quarter-approval-rating-below-average.aspx" target="_blank" rel="noreferrer noopener">approval</a> of 45%, slightly higher than the 41% recorded during the same period in his first term, per a Gallup report.
However, the figure still lags behind the 60% average enjoyed by other presidents during their early terms since 1952, per a <a target="_blank" href="https://www.nytimes.com/interactive/polls/donald-trump-approval-rating-polls.html" rel="noreferrer noopener">report </a>from the New York Times.
Also Read: <a target="_blank" href="https://www.benzinga.com/cannabis/25/05/45693219/feds-favorite-inflation-gauge-slows-but-trumps-china-accusation-flips-market-mood" rel="noreferrer noopener">Fed&#8217;s Favorite Inflation Gauge Slows, But Trump&#8217;s China Accusation Flips Market Mood</a>
As of May 30, the New York Times&#8217; polling aggregator placed Trump&#8217;s approval rating at 45%, with 52% disapproval.
&#8220;Our average has shown a slight uptick in President Trump&#8217;s approval rating recently,&#8221; writes Ruth Igielnik, Staff editor.
The YouGov/Yahoo News poll <a target="_blank" href="https://www.scribd.com/document/869057574/Yahoo-News-YouGov-Afrikaner-Poll-May-2025" rel="noreferrer noopener">reported </a>41% approval versus 54% disapproval, while a YouGov/Economist survey <a target="_blank" href="https://d3nkl3psvxxpe9.cloudfront.net/documents/econTabReport_WokQXF7.pdf" rel="noreferrer noopener">measured </a>approval at 44% and disapproval at 52%, USA Today reports.
In contrast, a Morning Consult poll <a target="_blank" href="https://pro.morningconsult.com/trackers/donald-trump-congress-policy-republicans-polling" rel="noreferrer noopener">placed </a>Trump&#8217;s approval higher at 48%, with disapproval at 51%.
A separate RMG Research poll <a target="_blank" href="https://napolitannews.org/assets/pdfs/6839c74590fa0-gcm25-0528-toplines-trump-job-approal-and-most-important-issues.pdf" rel="noreferrer noopener">showed </a>Trump narrowly underwater with 49% approval and 50% disapproval.
Over the last week, Trump has made headlines for controversial actions, including granting clemency to a former governor, a rapper, and a gang leader.
He also <a target="_blank" href="https://www.benzinga.com/news/25/05/45610237/trump-targets-usa-hating-judges-immigrants-and-biden-in-capital-letters-on-memorial-day-fear-not-we-have-made-great-progress" rel="noreferrer noopener">addressed the nation on Memorial Day</a> and doubled down on trade tariffs after a court allowed their continued enforcement. Additionally, Trump proposed Canada&#8217;s inclusion in a U.S. missile defense plan—if the country <a target="_blank" href="https://www.benzinga.com/general/space/25/05/45636081/trump-dangles-golden-dome-missile-shield-says-its-free-if-canada-becomes-51st-state-king-charles-fires-back-the-true-north-is-indeed-strong-and-free" rel="noreferrer noopener">agrees to become the 51st state.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45603673/trumps-targeting-of-apple-isnt-random-analyst-says-its-a-calculated-move-for-maximum-political-gain" target="_blank" rel="noreferrer noopener">Trump's Targeting Of Apple Isn't Random — Analyst Says It's A Calculated Move For Maximum Political Gain</a></li>
</ul>
Image: Shutterstock/Shutterstock AI

Politics

Trump's Approval Ratings Continue To Remain Below Historical Averages

Ulike Air 10 IPL Hair Removal Device is making waves in the at-home beauty tech market—and for good reason. With powerful features designed to rival professional treatments, it's quickly become a go-to option for users seeking salon-level results from the comfort of their own homes.
Priced competitively and often discounted on major retail sites, the Ulike Air 10 stands out for both its performance and design. This latest model offers improved intensity, quicker treatment times, and enhanced user comfort, positioning it well above many rivals in the IPL (intense pulsed light) category. 
&#8220;The Air 10 is the result of a decade of focused IPL expertise — each feature, from Ice Cooling to SHR Mode, is built to deliver professional-grade results with unmatched comfort at home,&#8221;Ulike GM, Leona Liu told Benzinga. 
What Makes the Ulike Air 10 Stand Out?
The Air 10 uses a new-generation IPL dual-light technology that allows for more efficient energy transfer, resulting in faster results with fewer sessions. Most users begin noticing visible hair reduction within just three weeks of regular use. What's especially impressive is the built-in sapphire ice-cooling system that keeps skin temperature regulated during sessions, dramatically minimizing pain or discomfort—something even high-end devices often lack.
Another thoughtful feature is the ergonomic, lightweight design. Unlike bulkier models, the Air 10 fits comfortably in hand, making it easy to target hard-to-reach areas like the bikini line or underarms. The device also includes multiple intensity settings, allowing users to adjust based on skin tone and sensitivity, an important consideration for safe at-home use.
How It Compares to Other Devices
Compared to devices like the RoseSkinCo Lumi, the Ulike Air 10 offers more robust performance and advanced features. While the Lumi is appreciated for its simplicity and lower price point, it lacks features like skin-cooling tech and the same level of intensity control. For those new to IPL or using it on small areas, Lumi may suffice, but for more permanent, full-body results, Air 10 leads the pack.
SheKnows praised the Ulike Air 10 for delivering "professional-level results" at home and called it one of the most effective and comfortable devices in its category. In contrast, alternatives like the SEMINO Advanced Lumea Ace cater to users looking for basic functionality at a reduced cost but may require more frequent treatments to achieve the same outcomes.
Value and Verdict
The Ulike Air 10 IPL usually retails at a premium price point, but ongoing deals often bring the cost down significantly. Recent discounts have made it one of the best-value premium IPL devices currently available. It also comes with a generous warranty and helpful customer support, adding more value to the purchase.
The Bottom Line: If you&#8217;re serious about long-term hair reduction and want a device that balances power, comfort, and speed, the Ulike Air 10 is worth the investment. Its thoughtful design and proven effectiveness make it a top-tier choice in the growing world of home-based beauty tech.

Ulike Air 10 Review: Why Beauty Experts Are Calling It a Game-Changer

Pop artist Kesha is expanding her influence beyond music and into the tech sector with last week's<a href="https://www.instagram.com/p/DJ9jYzwurcB/?igsh=MWE5MHlsNWtmdmhyaA%3D%3D&amp;img_index=3"> announcement</a> of her new startup, Smash, a platform aimed at empowering music creators through collaboration, transparency, and rights protection.
The initiative marks the artist's formal entrance into the <a href="https://www.benzinga.com/news/25/05/45642134/alation-just-bought-numbers-station-an-18-person-ai-startup-born-at-stanford-backed-by-intel-ceo-lip-bu-tan-and-tableaus-mark-nelson">startup</a> world. Kesha, who recently regained ownership of her music and voice following a high-profile legal battle with her former producer, is seeking to rewrite the rules of an industry she calls deeply flawed, according to<a href="https://www.wired.com/story/kesha-smash/"> Wired</a>.
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
</ul>
&#8220;After what I&#8217;ve gone through and seeing the things that I&#8217;ve seen, seeing that the system is really broken. It&#8217;s gatekeeping by people that can do what they want,&#8221; Kesha told Wired in an interview.
<h2 class="wp-block-heading">Smash Seeks To Rebuild The Industry With A Creator-First Approach</h2>
According to Kesha, Smash is envisioned as a &#8220;LinkedIn for music creators&#8221; with a &#8220;Fiverr-style marketplace&#8221; where <a href="https://www.benzinga.com/general/entertainment/24/04/38060686/over-200-artists-including-billie-eilish-and-katie-perry-demand-ai-respect-for-music-rights">artists</a> can offer services, hire one another, and collaborate without giving up rights to their intellectual property. She emphasized to Wired that the platform will eliminate gatekeeping, offering musicians a space to network without needing third-party intermediaries.
&#8220;I want a place where artists and music makers of any kind can have community, they can collaborate, they can hire each other and retain all the rights to everything they create,&#8221; Kesha said. &#8220;There's no gatekeeping of contacts.&#8221;
According to Wired, the platform is currently in its seed funding stage, with no official launch date set.
Trending: <a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a>
<h2 class="wp-block-heading">The Startup Is Led By Seasoned Tech Talent From Apple And Facebook</h2>
According to<a href="https://techcrunch.com/2025/05/23/kesha-is-now-a-startup-founder/"> TechCrunch</a>, Kesha has brought in Alan Cannistraro as Smash's chief technology officer. Cannistraro is a seasoned software engineer who spent 12 years at Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), contributing to the development of early iOS apps. He later joined Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), where he created the popular Year-In-Review feature for Facebook.&nbsp;
Cannistraro also previously founded the social video startup Rheo. His background in building user-centric software products positions Smash with a strong technical foundation, TechCrunch reports.
<h2 class="wp-block-heading">Kesha&#8217;s Personal Mission Energized By Industry Experience</h2>
The inspiration for Smash came to Kesha during what she described as a psychedelic experience that helped clarify her purpose. The app, she told Wired, is about &#8220;building the next dimension&#8221; for creatives who are often underpaid, undervalued, or exploited by traditional music business structures.
&#8220;I want to make sure what happened to me never happens to anyone else again,&#8221; she said.
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
Smash arrives as the creator economy continues to grow. According to<a href="https://www.midiaresearch.com/blog/state-of-the-music-creator-economy-the-consumer-era"> MIDiA Research</a>, there were nearly 75.9 million music creators globally at the end of 2023, with that number expected to exceed 198.2 million by 2030.
Along with Smash, Kesha is also preparing to release her sixth studio album, symbolically titled &#8220;.&#8221;, under her own independent label, Kesha Records, on July 4. The timing coincides with her U.S. tour, which is her first as a fully independent artist, Wired reports.
Backed by experienced engineering talent and informed by firsthand industry challenges, Smash may become a key player in reshaping how music creators connect, collaborate, and protect their rights.
Read Next: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a>
Image: Shutterstock

AAPL

Pop Icon Kesha Says 'The System Is Broken' As She Launches Smash, A Fiverr-Style Music App Backed To Lead A Creative Revolution

Many Americans are stuck <a href="https://www.benzinga.com/personal-finance/25/02/43947512/dave-ramsey-baffled-by-family-living-paycheck-to-paycheck-on-600000-a-year-why-do-you-need-18000-a-month-to-run-your-household">living paycheck to paycheck</a>, and it's not just because they don't make enough money. While low wages and the <a href="https://www.benzinga.com/25/03/44420778/us-consumers-face-risks-as-rising-cost-of-living-job-market-cracks-threaten-spending-bank-of-america-warns">rising cost of living</a> are factors, Reddit users recently shared a much broader picture of the problem, revealing how complex and widespread the issue really is.
<h2 class="wp-block-heading">It's More Than Just Low Wages</h2>
&#8220;At first glance, it seems obvious: people just don't make enough money, right?&#8221; one Redditor <a href="https://www.reddit.com/r/budget/comments/1kprv28/what_is_the_main_cause_to_americans_living/">wrote</a>. &#8220;But the more I read and the more conversations I had, the more I realized that income is only one piece of a much bigger puzzle.&#8221;
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
</ul>
Many pointed to the rising cost of living. Essentials like rent, food, healthcare, and transportation have surged, while wages have barely moved. &#8220;The cost of living has doubled and we&#8217;re still getting paid the same ridiculous salary,&#8221; one person wrote.&nbsp;
Even people who do save find themselves drained by constant emergencies. &#8220;I was just starting to feel good! Caught up on bills, <a href="https://www.benzinga.com/personal-finance/25/04/44656837/build-your-retirement-portfolio-while-saving-for-emergencies-a-roth-ira-can-double-as-an-emergency-fund-is-that-true">saving for emergencies</a>, finally contributing to my retirement then a random light flashes on my car dashboard,&#8221; someone shared. &#8220;There goes all the emergency money I built up.&#8221;
Medical bills, vet visits, car repairs, and home maintenance were frequently mentioned. &#8220;No amount of budgeting works when the average pay in the USA isn't enough to pay for rent if you're single,&#8221; another said.
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
Several people criticized the U.S. credit system, which can <a href="https://www.benzinga.com/personal-finance/25/05/45602529/after-a-4-year-pause-student-loans-are-destroying-credit-scores-one-borrower-says-it-cost-her-137-points-in-weeks">penalize people</a> for paying off debt. &#8220;I paid off my mortgage, car, and my student loans were discharged&#8230; and my credit score never recovered,&#8221; one wrote. Others said they were forced into debt <a href="https://www.benzinga.com/personal-finance/25/01/43085752/its-a-bankers-scam-dave-ramsey-blasts-the-fico-score-system-i-cant-rent-an-apartment-but-i-can-write-a-check-for-the-whole-complex">just to build credit</a> in the first place.
<h2 class="wp-block-heading">Spending Habits And Financial Literacy</h2>
There was also recognition that habits play a role. Some admitted to lifestyle creep or impulse spending. &#8220;If I have $100, why wouldn't I spend it on dinner or new whatever I need? I have it now, so I spend it now,&#8221; one person confessed. Another called it a mindset shaped by childhood poverty: &#8220;I learned that money doesn&#8217;t stick around. If you have $100 then you need to spend it on what it needs to go to or something else will &#8216;eat it.'&#8221;
Still, many said they weren't taught how to manage money in the first place. &#8220;We're basically thrown into adulthood without a map. So people just figure it out as they go—often by trial and error,&#8221; the original poster said. &#8220;And when that &#8216;error&#8217; is maxing out a credit card or missing rent, the consequences are heavy.&#8221;
See Also: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
<h2 class="wp-block-heading">No Easy Fix</h2>
There was little illusion that the situation would improve without major changes. &#8220;You have to be real and live within your means. If you are poor, live like you are poor until you work your way out,&#8221; one person wrote.&nbsp;
Others pushed back, saying the issue isn't discipline but systemic failure. As one commenter put it: &#8220;It&#8217;s too expensive to live, too expensive to have kids, and too expensive to die here in the U.S.&#8221;
Read Next:
<ul class="wp-block-list">
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

What's Driving Americans To Live Paycheck To Paycheck? One Person Says It's Like Being 'Thrown Into Adulthood Without A Map'

Tesla CEO Elon Musk once took to social media to question the lack of a publicly released client list in the Jeffrey Epstein&#8211;Ghislaine Maxwell case.
What Happened: In mid-2022, Elon Musk took to Twitter, now known as X, to question the lack of transparency surrounding the Epstein-Maxwell case. 
He pointedly asked why the Justice Department hadn't disclosed the list of clients linked to the duo and why mainstream media showed little interest in pursuing those identities. 
Alongside his post, Musk shared a collage featuring mythical creatures like unicorns and dragons, with the phrase &#8220;Epstein/Maxwell client list&#8221; included — implying it was something as unlikely to be seen as the others.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Only thing more remarkable than DOJ not leaking the list is that no one in the media cares. Doesn't that seem odd? <a href="https://t.co/JEK4TErABB">pic.twitter.com/JEK4TErABB</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1533161114586042369?ref_src=twsrc%5Etfw">June 4, 2022</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Maxwell, a once-prominent socialite, was handed a 20-year prison sentence in 2022 for her role in Epstein&#8217;s sex trafficking operation. She has since launched an appeal against her conviction and sentence, citing&nbsp;juror misconduct, a violation of&nbsp;the statute of limitations, and her treatment in prison as the grounds for her appeal.
Also Read:&nbsp;<a href="https://www.benzinga.com/news/25/03/44067638/elon-musk-claims-rival-billionaire-wants-to-destroy-trump-to-suppress-jeffrey-epstein-client-list">Elon Musk Claims Rival Billionaire Wants to &#8216;Destroy&#8217; Trump To Suppress Jeffrey Epstein Client List</a>
In response to Musk&#8217;s post on Twitter, a user posted a photograph of Maxwell and Musk together at a Vanity Fair Oscar party. Musk quickly responded, asserting that Maxwell had photobombed him.
In December 2021, Maxwell was found&nbsp;<a href="https://www.dailywire.com/news/ghislaine-maxwell-jeffrey-epsteins-former-girlfriend-found-guilty-in-sex-abuse-trial" target="_blank" rel="noreferrer noopener">guilty</a><a href="https://www.benzinga.com/news/21/12/24823587/epstein-associate-ghislaine-maxwell-found-guilty-of-5-charges-in-sex-trafficking-case" target="_blank" rel="noreferrer noopener">&nbsp;of helping to recruit teenage girls</a>&nbsp;for&nbsp;Epstein, who&nbsp;died in August 2019.
Maxwell, who is also identified as &#8220;Inmate 02879-509,&#8221;&nbsp;is currently serving her sentence&nbsp;at the Federal Correctional Institution&nbsp;in Tallahassee, Florida.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Ah yes, Maxwell photobombing me at a <a href="https://twitter.com/VanityFair?ref_src=twsrc%5Etfw">@VanityFair</a> Oscars party – you should them why they invited her. The same people who push this photo say nothing about prominent people who actually went to his island a dozen times. Also very strange …
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1533163139470180353?ref_src=twsrc%5Etfw">June 4, 2022</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Where is their "client" list? Shouldn't at least one of them go down!?
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1521186612457132034?ref_src=twsrc%5Etfw">May 2, 2022</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Musk&#8217;s call for transparency in the Epstein-Maxwell case comes amid a broader societal push for accountability in high-profile criminal cases. 
His comments have sparked a debate about the role of public figures in advocating for justice and transparency.
However, Musk&#8217;s interaction with the Twitter user who posted the photograph of him with Maxwell has also raised questions about his own connections to the case. 
While Musk has denied any involvement, the incident underscores the scrutiny public figures face in the age of social media.
Read Next
<a href="https://www.benzinga.com/general/social-media/24/11/42152805/elon-musk-agrees-that-people-want-to-see-jeffrey-epstein-files" target="_blank" rel="noreferrer noopener">Elon Musk Agrees That People Want To See Jeffrey Epstein Files</a>
Image: Shutterstock/Copyright Lawrey

TSLA

Elon Musk Once Asked Why Epstein-Maxwell Client List Hasn't Leaked — Here's How He Responded to X User Who Suggested He Was a Client

Victims of a substantial&nbsp;data breach are set to&nbsp;receive a portion of a $20 million settlement. Over five million affected users are in line to receive compensation for their losses.
What Happened: A court has granted preliminary approval for a multi-million dollar settlement to be distributed among victims of a data breach. The breach was linked to the file transfer platform of cybersecurity firm Fortra. 
The compromised data includes sensitive details such as names, addresses, Social Security numbers, and health insurance information.
According to a <a href="https://fortradatasettlement.com/">report</a>, the lawsuit was lodged against Fortra and several other companies, including rail service provider Brightline and&nbsp;healthcare firms Aetna, Community Health,&nbsp;Elevance Health, Imagine360, Intellihartx, NationsBenefits,&nbsp;and Santa Clara Family Health&nbsp;Plan.
Victims who can present &#8220;reasonable documentation for losses&#8221; from the 2023 data breach will receive up to $5,000. Without such documentation, class members will receive approximately $85. Claims must be submitted by August 29.
Also Read: <a href="https://www.benzinga.com/news/24/12/42716153/massive-data-breach-exposes-millions-of-credit-and-debit-cards-is-your-account-safe">Massive Data Breach Exposes Millions of Credit and Debit Cards—Is Your Account Safe?</a>
Besides the cash payment, class&nbsp;members are also eligible to&nbsp;receive dark web monitoring services&nbsp;for one year to mitigate&nbsp;potential identity theft and fraud risks.&nbsp;
The payments will be made&nbsp;once the court gives the&nbsp;class action settlement final approval, with a final approval hearing scheduled for mid-September.
Why It Matters: This settlement marks a significant victory for victims of data breaches, as it sets a precedent for future cases. It underscores the importance of cybersecurity and the potential financial consequences for companies that fail to adequately protect user data. 
The inclusion of dark web monitoring services in the settlement also highlights the growing recognition of the long-term risks associated with data breaches, including identity theft and fraud. 
This case serves as a reminder to companies of their responsibility to safeguard user data and the potential legal and financial repercussions of failing to do so.
Read Next
<a href="https://www.benzinga.com/tech/25/05/45336132/major-data-breach-exposes-social-security-numbers-financial-records-and-much-more">Major Data Breach Exposes Social Security Numbers, Financial Records and Much More</a>
Image: Shutterstock/Mdisk

Legal

Millions Impacted by Data Breach To Receive Cash, Free Monitoring in $20 Million Deal

During a recent meeting with President Donald Trump, Elon Musk was spotted with a black eye, which Musk said was the result of a playful incident with his son.
Musk&#8217;s visible bruise, noticed while he was standing next to Trump in the Oval Office on Friday.
According to a post on X, when asked about the injury, Musk explained,&nbsp;&#8220;I was just horsing around&nbsp;with Little X and I&nbsp;said, &#8216;Go ahead, punch me&nbsp;in the face.'&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Elon Musk just got asked why he has a black eye. <a href="https://t.co/8RScbhfdXv">pic.twitter.com/8RScbhfdXv</a>
&mdash; Blue Georgia (@BlueATLGeorgia) <a href="https://twitter.com/BlueATLGeorgia/status/1928521949719793897?ref_src=twsrc%5Etfw">May 30, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Little X, officially named X Æ A-Xii, is Musk&#8217;s eldest child with singer Grimes.
The child has often been seen with Musk during his tenure in office. Musk also humorously referred to a recent viral video involving France&#8217;s First Lady Brigitte Macron and French President Emmanuel Macron.
Also Read: <a href="https://www.benzinga.com/news/24/07/40001741/grimes-mother-accuses-musk-of-withholding-children-amid-custody-battle-please-elon-i-beg-you" target="_blank" rel="noreferrer noopener">Grimes&#8217; Mother Accuses Musk Of Withholding Children Amid Custody Battle: ‘Please Elon, I Beg You&#8217;</a>
In the meeting, President Trump lauded Musk&#8217;s contributions to&nbsp;the Department of Government Efficiency.&nbsp;Musk, who has been serving&nbsp;as a special government employee,&nbsp;was presented with&nbsp;a large key inside a&nbsp;wooden box as a token of appreciation. 
Friday marked Musk&#8217;s last official day in this role, after which he plans to refocus on Tesla.
Musk&#8217;s tenure as a special government employee has been marked by significant contributions to&nbsp;the Department of Government Efficiency.&nbsp;
His playful interaction with his son, leading to the black eye, showcases his personal side amidst his professional commitments. 
His departure from the government role indicates his intent to refocus on Tesla&#8217;s operations, which could signal upcoming developments for the electric vehicle giant.
Read Next
<a href="https://www.benzinga.com/general/social-media/25/05/45601162/elon-musks-father-open-to-more-children-despite-age-i-wouldnt-think-twice-about-having-another-child">Elon Musk&#8217;s Father Open to More Children Despite Age: &#8216;I Wouldn&#8217;t Think Twice About Having Another Child&#8217;</a>
Image: Shutterstock/cristiano barni

Social Media

Elon Musk Sports Black Eye in Oval Office: 'I Was Just Horsing Around With Little X and I Said, Go Ahead, Punch Me in the Face'

Gary Black, Future Fund LLC&#8217;s managing director and a prominent market analyst, has expressed concerns about Tesla Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) high forward price-to-earnings (P/E) ratio, questioning the sustainability of its current valuation.
What Happened: In a detailed thread on X on Saturday, Black pointed out that Tesla&#8217;s forward P/E ratio stands at a staggering 180x. He noted that no trillion-dollar market cap company in stock market history has traded at such a high forward P/E ratio. 
Black argued that the long-term growth rate required to justify such a P/E would make Tesla&#8217;s market cap larger than Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), which he deemed &#8220;insane.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24TSLA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$TSLA</a> now trades at a forward P/E of 180x. In the history of the stock market, we can't find a single $1T market cap company that traded at a forward P/E of 180x (we even asked Grok with no success). Why not? The long-term growth rate needed to justify a 180x P/E would cause…
&mdash; Gary Black (@garyblack00) <a href="https://twitter.com/garyblack00/status/1928866265117941880?ref_src=twsrc%5Etfw">May 31, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
&#8220;The long-term growth rate needed to justify a 180x P/E would cause TSLA market cap to be bigger than $AAPL and $MSFT, which seems insane since both have huge TAMs, unassailable brands, and highly predictable future cash flow streams,&#8221; he said in the post. 
Also Read: <a href="https://www.benzinga.com/tech/25/05/45687704/gary-black-says-teslas-robotaxi-launch-in-june-poses-minimal-risk-to-uber-will-offer-low-cost">Gary Black Says Tesla&#8217;s Robotaxi Launch In June Poses Minimal Risk To Uber: &#8216;Will Offer Low-Cost…&#8217;</a>
Black criticized Tesla bulls who dismiss his argument by claiming that&nbsp;the 2025 P/E is irrelevant.&nbsp;He emphasized that a stock&#8217;s&nbsp;valuation is the present value&nbsp;of all future cash flows,&nbsp;discounted back at a risk-adjusted&nbsp;cost of capital, plus net&nbsp;cash. To disregard P/E, according to Black, is equivalent to ignoring valuation&nbsp;when making an investment decision.
&#8220;TSLA bulls who pretend they understand finance dismiss my argument that TSLA's valuation looks stretched by saying the 2025 P/E is irrelevant. Rule #1 in investing is buy low, sell high. Rule #2 is price is what you pay, value is what you get. Arguing that P/E doesn't matter to an investment decision tells me the person doing the arguing has no valuation discipline and is just buying concepts, rather than on some assessment of value vs price,&#8221; Black continued. 
Why It Matters: Black&#8217;s comments come at a time when Tesla&#8217;s stock has been under scrutiny due to its high valuation. Despite the company&#8217;s impressive growth, some investors and analysts have raised concerns about whether its current stock price accurately reflects its future earnings potential. 
Black&#8217;s argument adds to this ongoing debate, highlighting the importance of traditional valuation metrics like P/E in assessing a company&#8217;s worth.
While Black clarified that he doesn&#8217;t foresee a situation where he would short Tesla, his comments underscore the need for investors to exercise caution and conduct thorough valuation assessments before making investment decisions.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45687331/elon-musks-right-hand-man-steve-davis-exits-doge-after-tesla-ceo-steps-back-from-government-work" target="_blank" rel="noreferrer noopener">Elon Musk's Long-Time Lieutenant Exits DOGE As Tesla CEO Steps Down From Government Work: Staffers At Agency Surprised</a></li>
</ul>
Image: Shutterstock/bluestork

MSFT

Gary Black Questions Tesla's Sky-High Forward P/E Ratio: 'Long-Term Growth Rate Needed To Justify a 180X P/E Would Cause Tsla Market Cap To Be Bigger'

Former NBA superstar Shaquille O&#8217;Neal has sold one of his Tesla Cybertrucks to fellow basketball player Trendon Watford, marking a shift in his vehicle preferences.
Shaq, renowned for his extensive car collection, chose to part ways with one of his three Tesla Cybertrucks. The vehicle, which had been customized and wrapped in a glossy maroon finish, was sold to Brooklyn Nets&#8217; Trendon Watford.
Despite previously expressing his admiration for the Cybertruck, Shaq recently voiced dissatisfaction with the vehicle&#8217;s range of 301 miles. 
As a result, he has transitioned to the Cadillac Escalade IQ, which features&nbsp;a 200KWH battery pack and&nbsp;a superior range of 460 miles.
The transaction was managed by Effortless Motors, who had listed the car for sale approximately a month ago. It is yet to be determined whether Shaq will sell his remaining Cybertrucks, following his recent change in sentiment towards the&nbsp;Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) vehicle.
Also Read: <a href="https://www.benzinga.com/general/sports/25/03/44209990/nba-legend-shaqs-walmart-shopping-spree-ends-in-credit-card-decline-heres-how-much-he-tried-to-spend" target="_blank" rel="noreferrer noopener">NBA Legend Shaq&#8217;s Walmart Shopping Spree Ends In Credit Card Decline—Here&#8217;s How Much He Tried To Spend</a>
<a href="https://www.benzinga.com/general/sports/25/05/45483236/shaq-rolls-up-in-a-cybertruck-elon-musk-has-this-one-word-response">Last year Tesla owner Elon Musk responded</a> to a post showcasing Shaq's Cybertruck with a simple "Nice", acknowledging the widebody modification and red under glow that make it one of the most eye-catching vehicles on the road.
Shaq&#8217;s decision to sell his Cybertruck may reflect a broader trend among consumers who are seeking electric vehicles with longer ranges. 
The Cadillac Escalade IQ&#8217;s superior range could potentially make it a more attractive option for consumers who frequently travel long distances. 
This shift in preference could impact Tesla&#8217;s market share in the electric vehicle industry, particularly if other high-profile individuals follow Shaq&#8217;s lead.
Read Next
<a href="https://www.benzinga.com/general/sports/25/03/44348149/shaq-once-spent-1-million-in-a-day-on-luxury-then-realized-taxes-took-a-huge-cut" target="_blank" rel="noreferrer noopener">Shaq Once Spent $1 Million in a Day on Luxury, Then Realized Taxes Took a Huge Cut</a>
Image: Shutterstock/Jonathan Weiss

Here's Why Shaquille O'Neal Gave Up Elon Musk's Cybertruck And Passed It To Another NBA Star

Billionaire investor and entrepreneur, Mark Cuban, has recommended teenagers explore artificial intelligence (AI) as a potential side hustle that could prove to be highly profitable.
What Happened: Cuban stated&nbsp;that if he were a&nbsp;teenager today, he would consider starting an AI side hustle. 
During a CNBC interview, he <a href="https://www.cnbc.com/2024/10/22/mark-cuban-if-i-was-a-teenager-again-id-start-this-ai-side-hustle.html">proposed </a>a three-step strategy: mastering AI language model prompts, teaching peers how to use&nbsp;these prompts for school assignments,&nbsp;and then offering&nbsp;these services to small and&nbsp;medium-sized businesses that have not yet embraced AI.
&#8220;Then, I would go to&nbsp;businesses, particularly small- to medium-sized&nbsp;businesses that don&#8217;t understand AI&nbsp;yet. Doesn&#8217;t matter if I&#8217;m&nbsp;16, I&#8217;d be teaching them&nbsp;as well,&#8221; Cuban said. 
As per a <a href="https://www.lendingtree.com/debt-consolidation/young-side-hustles-survey/">report </a>by LendingTree, over half of the Gen Z population&nbsp;in the U.S. are currently&nbsp;engaged in side hustles. AI&nbsp;prompt engineering, a field that involves crafting queries for chatbots to generate specific responses, could be a lucrative opportunity. 
Also Read:&nbsp;<a href="https://www.benzinga.com/news/24/10/41196856/heres-how-mark-cubans-drunken-splurge-of-125-000-turned-into-a-profitable-investment" target="_blank" rel="noreferrer noopener">Mark Cuban Drunkenly Bought A $125,000 Lifetime Flight Pass And Turned It Into A Profitable Investment</a>
ZipRecruiter <a href="https://www.ziprecruiter.com/t/Most-Popular-Types-Of-Ai-Prompt-Writing-Jobs">reports </a>that the average salary&nbsp;for AI tutors begins at&nbsp;around $30,000 per year,&nbsp;while full-time AI prompt engineers&nbsp;can earn up to $129,500.
While&nbsp;a college degree is not&nbsp;a prerequisite to become an&nbsp;AI prompt engineer, practice and&nbsp;often certifications are essential to&nbsp;comprehend how large language models&nbsp;function. Online certification programs from&nbsp;institutions like Vanderbilt University or&nbsp;IBM can assist&nbsp;in mastering the basics within&nbsp;a month.
Why It Matters: The advice from Cuban comes at a time when AI is increasingly becoming a part of our daily lives. From voice assistants to recommendation algorithms, AI is ubiquitous. 
With the growing demand for AI skills in the job market, Cuban&#8217;s advice could potentially guide teenagers towards a profitable and future-proof career. 
Furthermore, his strategy not only promotes self-learning and entrepreneurship among teenagers but also encourages them to help local businesses adopt AI, thereby fostering a community that is ready for the future.
Read Next
<a href="https://www.benzinga.com/top-stories/24/06/39241650/heres-how-mark-cuban-made-91-of-his-employees-millionaires" target="_blank" rel="noreferrer noopener">Here&#8217;s How Mark Cuban Made 91% Of His Employees Millionaires</a>
Image: Shutterstock

Success Stories

Mark Cuban Reveals the Side Hustle He'd Start at 16 — And It Doesn't Require a Degree

Elon Musk is alleged to have fathered a child with a Japanese pop star. The news, which surfaced on Friday, also includes Musk&#8217;s offer to <a href="https://www.benzinga.com/general/entertainment/25/02/43756965/conservative-influencer-says-musk-is-father-of-her-newborn-child">donate his sperm to &#8220;anyone.&#8221;</a>
Ashley St. Clair, who alleges to have a son with Musk, disclosed these details in a New York Times article on Friday.
Musk is claimed to have told her that he has fathered children worldwide, including&nbsp;with a Japanese pop star, and is willing to donate&nbsp;his sperm to anyone who&nbsp;wishes to have a child.
St. Clair also claimed that&nbsp;Musk was deeply worried about the declining birth rate and advocated for people to have more children. She further alleged that Musk insisted on keeping their relationship and his paternity a secret, even during her childbirth.
"He made it seem like it was just his altruism and he generally believed these people should just have children," St. Clair told the <a href="https://www.nytimes.com/2025/05/30/us/elon-musk-drugs-children-trump.html">outlet</a>.
Also Read: <a href="https://www.benzinga.com/news/24/07/40001741/grimes-mother-accuses-musk-of-withholding-children-amid-custody-battle-please-elon-i-beg-you" target="_blank" rel="noreferrer noopener">Grimes&#8217; Mother Accuses Musk Of Withholding Children Amid Custody Battle: ‘Please Elon, I Beg You&#8217;</a>
According to St. Clair, Musk offered her $15 million and an additional $100,000 monthly&nbsp;until their son turned 21&nbsp;to maintain her silence. 
However, she declined the offer and made the news public in February. She has also filed a lawsuit against Musk&nbsp;for child support and sole&nbsp;custody.
This revelation could potentially impact Musk&#8217;s public image and his role as the CEO of Tesla Inc. and SpaceX. The allegations, if proven true, may raise ethical questions about Musk&#8217;s conduct and his views on parenthood. 
The lawsuit filed by St. Clair could also lead to legal complications for the billionaire entrepreneur. The situation warrants close monitoring as it unfolds.
Read Next
<a href="https://www.benzinga.com/general/entertainment/25/02/43769279/elon-musk-addresses-conservative-influencer-st-clairs-allegations">Elon Musk Addresses Conservative Influencer St. Clair&#8217;s Allegations</a>
Image: Shutterstock/Frederic Legrand &#8211; COMEO

Ex Says Musk Told Her He Fathered Child With Japanese Pop Star, Said He Would Give Sperm To Anyone Who Wanted It

President Donald Trump said that he has no knowledge of Elon Musk engaging in drug use during the 2024 election cycle, brushing off a media report alleging Musk&#8217;s <a href="https://www.benzinga.com/cannabis/25/05/45700477/elon-musk-was-using-drugs-while-on-campaign-trail-with-trump-including-ecstasy-and-psychedelic-mushrooms" target="_blank" rel="noreferrer noopener">drug consumption while on the campaign trail</a>.
According to a recent piece by The New York Times, the billionaire entrepreneur <a href="https://www.nytimes.com/2025/05/30/us/elon-musk-drugs-children-trump.html" target="_blank" rel="noreferrer noopener">reportedly</a> consumed drugs such as ketamine, ecstasy, and psychedelic mushrooms during the campaign season, possibly while working with Trump.
The publication also noted uncertainty around whether these substances were used while Musk was involved with the Department of Government Efficiency.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/05/38907748/days-after-facing-lawsuit-for-drug-use-musk-says-he-would-take-cocaine-if-it-boosted-long-term-produ" rel="noreferrer noopener">Days After Facing Lawsuit For Drug Use, Musk Says He Would Take Cocaine If It Boosted &#8216;Long-Term Productivity&#8217;</a>
Trump, speaking to journalists on May 30 after an event in Pennsylvania, dismissed the allegations, praising Musk and stating, &#8220;I&#8217;m not troubled by anything with Elon,&#8221; USA Today <a target="_blank" href="https://www.usatoday.com/story/news/politics/2025/05/30/donald-trump-not-aware-of-elon-musks-reported-campaign-drug-use/83956424007/" rel="noreferrer noopener">reports</a>.
Musk, who heads Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and SpaceX, and also owns social media platform X, was present at an Oval Office event the same day.
When pressed by a reporter about the drug claims, he deflected the question and criticized the Times&#8217; previous reporting, particularly its coverage of alleged Russian interference in the 2016 election, the report adds.
In a social media post in X on May 31, Musk mocked the alleged claims made about his drug use.
&#8220;I&#8217;m in meetings with dozens to hundreds of people every day and am photographed constantly. If this bs from NYT were true, it would have been EXTREMELY obvious,&#8221; Musk wrote.
The tech mogul acknowledged in March 2024 that he takes prescription ketamine for depression.
His past conduct also includes a much-publicized incident in 2018 where he smoked marijuana during a podcast interview, which raised concerns among board members and shareholders.
The White House has not issued any formal statement on the matter. No additional evidence has been presented to substantiate the claims of drug use during government work.
Musk continues to be a polarizing figure, not only because of his business ventures but also due to his political engagements and public statements. His increasing visibility in Washington has only intensified scrutiny around his personal habits.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/topics/25/05/45709073/bono-tells-joe-rogan-that-300000-people-have-died-from-doge-led-usaid-cuts-elon-musk-calls-him-a-liar-says-zero-people-have-died" target="_blank" rel="noreferrer noopener">Bono Tells Joe Rogan That 300,000 People Have Died From DOGE-Led USAID Cuts: Elon Musk Calls Him A Liar, Says &#8216;Zero People Have Died&#8217;</a></li>
</ul>
Image: Shutterstock/Joshua Sukoff

Trump Says He's 'Not Troubled' By Musk's Alleged Drug Use During Campaign: Report

What do you get when you mix $1,000, an unemployed golf buddy, <a href="https://www.benzinga.com/personal-finance/25/04/45110288/99-year-old-billionaire-charlie-munger-said-iron-rule-of-life-is-everybody-struggles-but-you-have-to-soldier-through-its-your-only-option">and Charlie Munger's brain</a>? Apparently, a passive income stream that lasted decades. No hedge fund, no Wall Street pitch deck — just Munger, long before his Berkshire Hathaway days, spotting a scrappy oil royalty deal and turning it into one of the most quietly outrageous investments of his life.
And the best part? He didn't go it alone — he brought his unemployed friend along for the million-dollar ride.
Back in 1962, Munger was still practicing law in Los Angeles when he met Al Marshall, an out-of-work oil industry worker trying to buy mineral rights at auction.&nbsp;
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
</ul>
Munger, seeing the flaws in Marshall's strategy but liking the bones of the deal, decided to go in with him. Each put up $1,000 and bought into oil royalties through what was then a legal tax shelter known as an AB trust, which was later outlawed.
And the returns? Straight-up legendary.
"Fifty years later we were getting $100,000 a year on that investment," Munger told the crowd at the 2016 Daily Journal shareholder meeting. "The trouble with that story is that it only happened once."
He delivered it with a chuckle, but the message was clear: not every great investment is repeatable — which is exactly why you act when you spot one.
Munger touched on the story again during his final Daily Journal meeting in 2023, a full-circle moment near the end of his career, where he once more emphasized the rarity of those life-changing opportunities.
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
The story is backed by Janet Lowe's 2000 biography "Damn Right!," where Marshall said, "We only put up $1,000 each, and we've each probably made a half a million out of it." He added, "I'm still getting $2,000 to $3,000 a month from that," confirming the checks were still rolling in decades later.&nbsp;
That's right — from a $1,000 investment, Munger's family was still cashing royalty checks well into the 21st century. All from a single, overlooked opportunity.
Of course, Munger never sugarcoated it. "The trick in life," he told that 2016 crowd, "is when you get the one, or two, or three [big opportunities] that your fair allotment for a life is — that you've got to do something about it."
And if you're still grinding toward that first big win? He had advice for that, too: <a href="https://www.benzinga.com/personal-finance/25/02/43759618/charlie-munger-said-the-hardest-part-of-getting-rich-is-the-first-100000-but-from-there-it-snowballs-and-you-can-ease-off-the-gas">"The first $100,000 is a b&#x2A;tch, but you gotta do it."</a>
Hard work. A sharp eye. A little luck. And when the rare opportunity does show up? Move fast — because even for Charlie Munger, it only happened once.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
</ul>
Image: Shutterstock

Charlie Munger Turned $1,000 Into Over $1 Million — And Made His Unemployed Friend Rich Too: 'Trouble With That Story Is It Only Happened Once'

A cold email to billionaire Mark Cuban by Aaron Levie, co-founder cloud storage and file-sharing business Box, was the catalyst for the company&#8217;s current valuation of $4.6 billion.
What Happened:&nbsp;Back in 2005, Levie, then a University of Southern California student, was on the hunt for funding for his startup. He took the initiative to send cold emails to potential investors, including Cuban.
Within a few hours, Cuban replied, suggesting a partnership on a data-hosting project. This idea later evolved, and Cuban invested $350,000 in Box without ever meeting the co-founders face-to-face. 
This investment marked a significant milestone for Box, encouraging Levie to leave college and dedicate his full attention to the company.
Levie&#8217;s pitch to Cuban was straightforward: with the cost of online data storage dropping and internet speeds increasing, there was a golden&nbsp;opportunity for a company to&nbsp;simplify secure online data storage. Despite receiving hundreds of email pitches daily, Cuban was swayed by this proposition.
Also Read: <a href="https://www.benzinga.com/news/25/03/44348044/mark-cuban-reveals-what-hed-do-as-a-gen-zer-to-get-ahead-even-while-sleeping-if-i-was-16-18-20-21-starting-today-i-would-spend-every-waking-minute-learning-it">Mark Cuban Reveals What He&#8217;d Do As A Gen Zer to Get Ahead—Even While Sleeping: &#8216;If I Was 16, 18, 20, 21 Starting Today, I Would Spend Every Waking Minute Learning It&#8217;</a>
"That was wild, because it happened so fast," Levie <a href="https://www.cnbc.com/2025/05/19/box-co-founder-cold-email-to-mark-cuban-landed-startup-investment.html">told </a>CNBC. &#8220;Cuban's funding represented Box's breakthrough investment," he added. 
However, Cuban had a change of heart about a year after his investment due to disagreements over Box&#8217;s business model. In 2006, Box secured additional funding, and Levie used a portion of this capital to repurchase Cuban&#8217;s stake.
Despite the fallout, Cuban&#8217;s initial investment was instrumental in Box&#8217;s early growth. The company has been profitable since 2023, with a reported&nbsp;net income of $129 million&nbsp;in 2024.
Why It Matters:: Mark Cuban&#8217;s initial investment in Box underscores the power of cold emailing and the potential it holds for startups seeking funding. 
Despite Cuban&#8217;s eventual exit, his early confidence in the company provided the necessary boost for Box&#8217;s growth. 
This story serves as a reminder of the importance of persistence, a clear vision, and the courage to seize opportunities in the entrepreneurial world.
Read Next
<a href="https://www.benzinga.com/news/25/02/43581429/mark-cubans-400k-bet-on-teen-founder-comes-with-an-unexpected-invitation-i-want-my-daughters-to-meet-you-and-learn-from-you" target="_blank" rel="noreferrer noopener">Mark Cuban&#8217;s $400K Bet On Teen Founder Comes With An Unexpected Invitation: ‘I Want My Daughters To Meet You, And Learn From You&#8217;</a>
Image: Shutterstock/T. Schneider

This 20-Year-Old Emailed Mark Cuban, Got $350K — Now His Company Is Worth $4.6 Billion

Press Releases

CRISPR Therapeutics to Present at the Guggenheim SMID Cap Biotech Conference

Earnings

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Health Care

CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

The Future of Stem Cell Investing: Spotlight on Smaller Innovators

Management

CRISPR Therapeutics Announces Transition of Chief Operating Officer

Stem Cell Innovators: 4 Companies Advancing Regenerative Medicine

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

General

CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

ADIA

BLUE

FATE

MESO

JMP Securities

Needham

HC Wainwright & Co.

Barclays

Goldman Sachs

2025년 4월 4일 금요일에 캐시 우드가 이끄는 아크 인베스트는 코인베이스 글로벌(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), 아마존닷컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), 크리스퍼 테라퓨틱스 AG(NGM:<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/crsp" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for CRSP">CRSP</a>), 빔 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>), 유아이패스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>), 로블록스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>), 메르카도리브레(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>), 그리고 리페어 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPTX#NASDAQ">RPTX</a>)를 포함한 여러 저명한 기업에 대해 상당한 거래를 했다.
COIN 거래
아크 인베스트는 여러 ETF를 통해 코인베이스 글로벌의 주식을 구매했다. 아크 인베스트의 ARK 핀테크 혁신 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>)는 12,187주를 구매했으며, ARK 혁신 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)와 ARK 차세대 인터넷 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>)는 각각 54,988주와 15,982주를 추가했다.
구매된 COIN 주식의 총 가치는 마지막 종가 160.55달러를 기준으로 약 1350만 달러에 해당한다.
AMZN 거래
아마존닷컴도 아크 인베스트로부터 상당한 매수세를 보았다. ARKF, ARKK, 그리고 ARK 자율 기술 및 로보틱스 ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKQ#BATS">ARKQ</a>)는 각각 9,018주, 25,528주 및 8,408주를 구매했다.
아마존의 마지막 종가가 171.0달러인 점을 고려할 때, 구매된 주식의 총 가치는 약 740만 달러이다.
CRSP 및 BEAM 거래
ARKK 기금은 크리스퍼 테라퓨틱스 AG의 69,011주와 빔 테라퓨틱스의 142,713주를 구매했다. 각각의 마지막 종가가 32.65달러와 15.27달러인 점을 바탕으로, 구매된 CRSP 및 BEAM 주식의 총 가치는 약 350만 달러이다.
PATH 거래
아크 인베스트의 ARKK는 유아이패스 주식회사의 448,505주를 매도했으며, ARKQ는 147,575주를 매도했다. ARK 차세대 인터넷 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>)는 323,575주를 매도했으며, ARKF 기금은 434,637주를 매도했다.
RBLX, MELI, 및 RPTX 거래
아크 인베스트는 로블록스와 메르카도리브레의 주식을 여러 ETF를 통해 매도했다. 또한, ARKG 기금은 리페어 테라퓨틱스의 32,613주를 매도했으며, 이는 마지막 종가 1.0달러를 기준으로 약 32,613달러에 해당한다.
다음 읽기:
<ul>
<li><a href="https://www.benzinga.com/25/04/44652222/trumps-tariffs-may-shift-us-spending-from-goods-to-services-creating-uncertainty-for-ecommerce-and-advertising-industries-analyst-warns">관세가 최종 수요에 영향을 미칠 것: 골드만삭스 분석가가 기업 지출 및 고용에 대한 저항을 예상한다</a> </li>
</ul>
면책 조항: 이 콘텐츠는 부분적으로 AI 도구의 도움을 받아 작성되었으며, Benzinga 편집자에 의해 검토 및 게시되었다.
사진 출처: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

화요일(11일) 캐시 우드의 아크 인베스트는 템퍼스AI(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>), 블록(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>), 드래프트킹스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>)과 관련해 주목할 만한 거래를 시행했다. 이는 시장 변동성과 아크 인베스트의 전략적 포지셔닝 속에서 나타났다.
<h3>템퍼스AI 거래</h3>
아크 인베스트의 ARK Innovation ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)가 종가 45.58달러를 기준으로 약 429만 달러에 달하는 템퍼스AI 주식 94,251주를 대량으로 매입했다. 템퍼스AI는 최근 4분기 실적을 발표하면서 매출은 감소했지만 주당순이익은 증가했다고 밝혔다. 매출 부진에도 불구하고 회사는 강력한 가이던스를 제시했으며, 이는 아크 인베스트의 지분 확대 결정에 영향을 미쳤을 수 있다.
최근 기술 업종 침체로 특징지어지는 시장 환경에서 아크 인베스트는 템퍼스AI와 같은 기업의 주식을 적극적으로 인수하고 있다. 월요일(10일) 기술주 폭락 속에서 우드는 1,323만 달러 상당의 <a href="https://www.benzinga.com/25/03/44239652/cathie-wood-goes-on-shopping-spree-amid-tech-bloodbath-monday-loads-up-on-tesla-palantir-coinbase-and-these-stock" target="_blank" rel="noopener">템퍼스AI 주식을 매입했다.</a>
<h3>블록 거래</h3>
같은 날, 아크 인베스트의 ARKK ETF는 비트코인(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) 중심 기업 블록의 주식 203,659주를 종가 55.29달러에 약 1,126만 달러에 매각했다. 블록의 최근 실적 보고서에 따르면 매출이 <a href="https://in.benzinga.com/news/earnings/25/02/43867724/block-shares-sink-after-q4-revenue-miss-ceo-jack-dorsey-expects-to-end-year-at-rule-of-40-run-rate" target="_blank" rel="noopener">예상치에 미치지 못했다.</a>
매출 부진에도 불구하고 블록의 CEO인 잭 도시(Jack Dorsey)는 연말까지 "Rule of 40"을 달성할 수 있을 것으로 낙관하고 있다.
<h3>드래프트킹스 거래</h3>
아크 인베스트는 ARK Next Generation Internet ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>)를 통해 드래프트킹스 보유 지분을 줄였다. 이는 종가 38.66달러를 기준으로 약 896,718달러에 해당한다. 드래프트킹스는 최근 스포츠 베팅 업계가 어려운 시기에 <a href="https://www.benzinga.com/general/sports-betting/25/02/43748897/draftkings-lost-some-games-but-won-the-quarter-analyst" target="_blank" rel="noopener">예상치를 하회한 매출</a>을 포함한 4분기 실적을 발표했다.
매출 부진에도 불구하고 애널리스트들은 드래프트킹스의 회복력과 미래 성장 잠재력을 강조했다.
<h3>기타 주요 거래</h3>
<ul>
<li>ARKF, ARKQ, ARKK 통해 로쿠(ROKU) 주식 매도</li>
<li>ARKF와 ARKW 통해 이보타(IBTA) 주식 매수</li>
<li>ARKF, ARKK, ARKW 통해 로블록스(RBLX) 주식 매도</li>
<li>ARKG 통해 케어Dx(CDNA) 주식 매도</li>
<li>ARKK, ARKG 통해 크리스퍼 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>) 주식 6,495주 매수</li>
</ul>
이미지: Shutterstock 
이 기사는 <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a>를 사용하여 생성되었으며, <a href="https://www.benzinga.com/author/shivdeep-dhaliwal">Shivdeep Dhaliwal</a>이 편집했습니다.
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

이들 10개 대형주는 지난 주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 위라이드(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRD#NASDAQ">WRD</a>)의 주식이 97.62% 급등했다. 이는 엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)가 13F 제출을 통해 174만 주의 지분을 보유하고 있다고 공개한 후 발생한 일이다.
2. GDS 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>)의 주식이 43.45% 상승했다. 이는 트럼프 대통령이 중국에서 오는 $800 이하의 소포에 대한 관세를 연기했다고 보도된 후 발생한 일이다. 또한, 중국의 딥시크(DeepSeek) AI 모델에 대한 낙관론도 최근 주가를 끌어올렸다.
3. 스프링웍스 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWTX#NASDAQ">SWTX</a>)의 주식이 42.58% 상승했다. 이는 머크 그룹(OTC:<a class="ticker" href="https://www.benzinga.com/stock/MKGAF#OTC">MKGAF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MKKGY#OTC">MKKGY</a>)가 회사를 인수하기 위한 고급 논의를 진행 중이라고 발표한 후 발생한 일이다.
4. 리커젼 파마슈티컬스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>)의 주식이 40.59% 증가했다.
5. 세이블 오프쇼어(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOC#NYSE">SOC</a>)의 주식이 39.09% 상승했다.
6. 진DX 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGS#NASDAQ">WGS</a>)의 주식이 28.23% 상승했다. 이는 회사가 울트라래피드 전장유전체 시퀀싱(UltraRapid Whole Genome Sequencing)을 발표하여 48시간 내에 실행 가능한 결과를 제공한다고 발표한 후 발생한 일이다.
7. 브이넷 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNET#NASDAQ">VNET</a>)의 주식이 28.22% 상승했다. 이는 지난 주 중국의 딥시크 AI 모델과 관련된 AI 경쟁 우려로 하락한 후 반등 가능성이 제기된 것으로 보인다.
8. 인스페리티(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>)의 주식이 25.99% 증가했다. 이는 회사가 예상보다 좋은 4분기 결과를 발표한 후 발생한 일이다.
9. 크리스퍼 테라퓨틱스 AG(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>)의 주식이 25.21% 상승했다. 이는 회사가 예상보다 좋은 4분기 재무 결과를 발표한 후 여러 애널리스트들이 주가 전망을 상향 조정한 후 발생한 일이다.
10. 액섬 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXSM#NASDAQ">AXSM</a>)의 주식이 24.01% 상승했다. 이는 회사가 테바 파마슈티컬(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>)과의 모든 특허 소송을 해결하기 위한 합의에 도달한 후 발생한 일이다. 여러 애널리스트들이 주가 전망을 상향 조정했다.
다음 읽기:
<a href="https://kr.benzinga.com/news/usa/stocks/%EC%8A%88%ED%8D%BC-%EB%A7%88%EC%9D%B4%ED%81%AC%EB%A1%9C-%EC%9D%B8%ED%85%94-%EC%95%8C%EB%A6%AC%EB%B0%94%EB%B0%94-%EB%B0%8F-cvs-%EB%93%B1-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%83%81%EC%8A%B9%ED%95%9C-12/" target="_blank" rel="noopener">슈퍼 마이크로, 인텔, 알리바바 및 CVS 등 지난주 상승한 12개 대형주 (2월 10일-2월 14일)</a>
<a href="https://kr.benzinga.com/news/usa/stocks/%EB%A0%88%EB%94%A7-%EA%B3%A0%EB%8C%80%EB%94%94-%EB%B0%8F-%ED%8A%B8%EB%A0%88%EC%9D%B4%EB%93%9C-%EB%8D%B0%EC%8A%A4%ED%81%AC%EB%8A%94-%EB%93%B1-%EC%A7%80%EB%82%9C%EC%A3%BC-%ED%95%98%EB%9D%BD%ED%95%9C-11/" target="_blank" rel="noopener">레딧, 고대디 및 트레이드 데스크는 등 지난주 하락한 11개의 대형주 (2월 10일~2월 14일)</a>
사진 출처: WeRide
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

금요일에 캐시 우드가 이끄는 아크 인베스트가 크리스퍼 테라퓨틱스 AG(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>), 10X 지노믹스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXG#NASDAQ">TXG</a>), 로블록스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>), 아처 에비에이션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>), 누 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NU#NYSE">NU</a>), 아디옌 NV(OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADYEY#OTC">ADYEY</a>), 애콜레이드(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>) 그리고 에어로바이런먼트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>)와 관련된 주요 거래를 했다.
CRSP 거래
아크 인베스트는 ARK Genomic Revolution ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>)와 Ark Innovation ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)를 통해 크리스퍼 테라퓨틱스의 주식을 매수했다. ARKG ETF는 43,467 주를, ARKK ETF는 248,748 주를 매입했다.
같은 날의 종가인 41.59달러를 기준으로, 구매한 주식의 총 가치는 약 12.14 백만 달러에 해당한다.
TXG 거래
또 다른 중요한 매수는 10X 지노믹스였다. 아크 인베스트는 ARKG ETF에 11,137 주를 추가하고 ARKK ETF에 63,395 주를 추가했다. 종가가 15.00달러인 경우, 구매한 주식의 총 가치는 약 1.12 백만 달러이다.
RBLX 및 ACHR 거래
매도 측면에서는 아크 인베스트가 로블록스와 아처 에비에이션의 보유 주식을 줄였다. 이 회사는 ARKK ETF에서 RBLX 주식 46,459 주와 ACHR 주식 374,904 주를 매도했다. 각각의 종가가 71.07달러와 9.45달러인 경우, 매도된 주식의 총 가치는 약 4.12 백만 달러이다.
기타 주요 거래:
아크 인베스트는 ARKG ETF에서 애콜레이드 주식 307,632 주를 매도했다.
또한, ARK Next Generation Internet ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>)에서 누 홀딩스와 아디옌 NV의 보유 주식을 각각 300 주와 5,600 주로 줄였다.
아크 인베스트는 ARK Space Exploration &amp; Innovation ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>)에서 에어로바이런먼트 주식 2,671 주를 매도했다.
이 거래들은 아크 인베스트의 전략과 현재 집중하고 있는 섹터를 엿볼 수 있게 한다. 이 회사의 움직임은 역사적으로 강력한 성과로 인해 투자자들에 의해 주의 깊게 관찰되고 있다.
다음 읽기:
<a href="https://kr.benzinga.com/news/usa/stocks/%EC%95%84%ED%81%AC-%EC%9D%B8%EB%B2%A0%EC%8A%A4%ED%8A%B8-ai-%EA%B2%BD%EC%9F%81-%EA%B0%80%EC%97%B4-%EC%86%8D-%ED%8C%94%EB%9E%80%ED%8B%B0%EC%96%B4-%EC%A3%BC%EC%8B%9D-1%EC%B2%9C%EB%A7%8C-%EB%8B%AC/" target="_blank" rel="noopener">캐시 우드의 아크 인베스트가 AI 경쟁이 치열해짐에 따라 팔란티어 주식 1천만 달러 어치를 매각</a>
면책 조항: 이 콘텐츠는 AI 도구의 도움으로 부분적으로 제작되었으며, Benzinga 편집자에 의해 검토 및 게시되었습니다.
사진 제공: Ark Invest
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Biotech

ACCD

ACHR

ADYEY

ARKG

ARKX

AVAV

아크 인베스트 크리스퍼 테라퓨틱스 투자로 생명공학에 베팅, 로블록스에서 매도

구글 모기업 알파벳의 자회사인 스타트업 아이소모픽 랩스(Isomorphic Labs)는 올해 연말까지 최초의 인공지능(AI) 설계 의약품의 임상시험을 시작할 예정이다. 주요 기술 기업들이 AI 기반 의료 솔루션에 대한 투자를 늘리면서 제약 개발의 중요한 이정표가 될 것으로 보인다.
무슨 일 있었나: 다보스에서 열린 세계경제포럼에서 아이소모픽 랩스 설립자인 데미스 하사비스(Demis Hassabis)는 회사가 종양, 심혈관 질환, 신경 퇴화 등 주요 질병 분야를 목표로 하고 있다고 파이낸셜타임스와의 <a href="//www.ft.com/content/41b51d07-0754-4ffd-a8f9-737e1b1f0c2e"" target="_blank" rel="noopener">인터뷰에서 말했다.</a>
아이소모픽 랩스는 이미 6개의 신약 개발 프로그램을 위해 일라이 릴리(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) 및 노바티스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>)와 파트너십을 체결했다.
최근 노벨 화학상을 수상한 하사비스는 "보통 하나의 약을 발견하는 데 평균 5년에서 10년이 걸린다&#8221;며 &#8220;이를 10배로 단축할 수 있다면 인류 건강에 놀라운 혁명이 될 것&#8221;이라고 말했다.
왜 중요한가: 이번 아이소모픽 랩스의 발표는 오라클(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>)이 48시간 이내에 개인 맞춤형 치료를 제공할 수 있는 AI 기반 암 백신 시스템에 대한 계획을 발표한 이후 나온 것이다. 오라클의 이니셔티브는 <a href="https://www.benzinga.com/markets/equities/25/01/43118941/oracles-larry-ellison-says-cancer-vaccine-tailored-in-48-hours-could-soon-be-a-reality-as-trump-announces-500-billion-ai-investment" target="_blank" rel="noopener">5,000억 달러 규모의 AI 인프라 프로젝트</a> &#8216;스타게이트&#8217;의 일환으로 오픈AI 및 소프트뱅크 그룹과 협력한다.
최근 AI 기반 신약 개발에 대한 투자가 탄력을 받고 있으며, ARK 인베스트의 CEO인 캐시 우드는 <a href="https://www.benzinga.com/general/biotech/24/11/42206182/cathie-wood-sees-400b-opportunity-in-biologics-how-have-her-bets-fared" target="_blank" rel="noopener">향후 5년간 바이오로직스</a> 분야에서 4,000억 달러의 시장 기회가 있을 것으로 예상하고 있다. 이 분야는 투자자들로부터 상당한 관심을 받고 있지만, 크리스퍼 테라퓨틱스(Crispr Therapeutics AG)와 인텔리아 테라퓨틱스(Intellia Therapeutics Inc.) 같은 회사는 상당한 시장 변동성을 보였다.
2021년 구글 딥마인드에서 분사한 아이소모픽 랩스는 기술 대기업들이 AI를 활용해 전통적으로 기간이 길고 비용이 많이 드는 신약 개발 과정을 간소화하려는 추세를 반영한다.
이 기사도 읽어보세요: <a href="https://kr.benzinga.com/news/usa/stocks/%EB%A7%88%ED%8B%B4-%EC%8A%88%ED%81%AC%EB%A0%90%EB%A6%AC-%EC%B5%9C%EA%B7%BC-%EC%A3%BC%EA%B0%80-%EC%83%81%EC%8A%B9%EC%97%90%EB%8F%84-%EC%95%84%EC%9D%B4%EC%98%A8%ED%81%90%EB%A6%AC%EC%A0%9C/">마틴 슈크렐리, 최근 주가 상승에도 "아이온큐·리제티는 최고의 공매도 종목"</a>
이미지 제공: Shutterstock
면책 조항: 이 콘텐츠는 부분적으로 AI 도구의 도움을 받아 작성되었으며, Benzinga 편집자가 검토하고 게시했습니다.
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

GOOGL

NTLA

ORCL

알파벳 자회사 아이소모픽 랩스, 올해 말까지 AI가 설계한 신약 임상시험 예정

금요일에 캐시 우드가 이끄는 아크 인베스트(Ark Invest)가 템퍼스 AI(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>), 크리스퍼 테라퓨틱스 AG(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>), 유아이패스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>), 로블록스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>), 레딧(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>),애컬레이드(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>) 그리고 아이보타(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBTA#NYSE">IBTA</a>)와 관련된 중요한 거래를 진행했다.
템퍼스 AI 주식 거래
아크 인베스트의 Ark Genomic Revolution ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>)와 Ark Innovation ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)가 템퍼스 AI 주식을 대량으로 구매했다. ARKG 펀드는 27,188주를 매수했고, ARKK 펀드는 무려 159,344주를 구매했다.
종가가 35.15달러인 것을 기준으로 이 거래의 총 가치는 약 657만 달러에 달합니다. 이는 아크 인베스트가 최근 인공지능(AI) 기반 회사에 투자하는 추세와 일치한다.
CRSP 주식 거래
아크 인베스트의 ARKG와 ARKK 펀드도 크리스퍼 테라퓨틱스 주식을 구매했다. ARKG 펀드는 21,730주를 매수했고, ARKK 펀드는 125,690주를 추가했다.
종가가 40.53달러인 것을 기준으로 이 거래의 총 가치는 약 596만 달러이다.
PATH, RBLX, RDDT 주식 거래
반면, 아크 인베스트는 유아이패스, 로블록스 그리고 레딧의 주식을 매도했습니다. ARKK 펀드는 유아이패스의 주식 199,224주, 로블록스의 주식 148,591주를 매도하고, ARKW 펀드는 레딧의 주식 5,215주를 매도했다.
이 매도는 아크 인베스트의 포트폴리오 전략의 변화를 나타낸다.
기타 주요 거래:
<ul>
<li>아이보타: 아크 인베스트의 Ark Fintech Innovation ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>) 펀드가 아이보타 주식 4,364주를 매수했다.</li>
<li>애컬레이드.: ARKG 펀드가 애컬레이드의 주식 284,775주를 매도했다.</li>
</ul>
다음 읽기:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EC%BA%90%EC%8B%9C-%EC%9A%B0%EB%93%9C%EC%9D%98-%EC%95%84%ED%81%AC-%EC%9D%B8%EB%B2%A0%EC%8A%A4%ED%8A%B8-%ED%8C%94%EB%9E%80%ED%8B%B0%EC%96%B4-%EC%A3%BC%EA%B0%80-%ED%95%98%EB%9D%BD-%EC%86%8D-%EC%B6%94/" target="_blank" rel="noopener">캐시 우드의 아크 인베스트, 팔란티어 주식 다시 매도 &#8211; 2025년 첫 2주간 주가 15% 이상 하락</a></li>
</ul>
면책 조항: 이 콘텐츠는 AI 도구의 도움을 받아 부분적으로 생성되었으며, Benzinga 편집자가 검토하고 발행했습니다.
이미지 출처: Benzinga YouTube 및 Unsplash
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

IBTA

RDDT

아크 인베스트, 금요일 템퍼스 AI·크리스퍼 테라퓨틱스 매수 vs 유아이패스·로블록스·레딧 매도

아크 인베스트먼트 매니지먼트 설립자이자 CEO인 캐시 우드는 최근 소파이(SoFi)의 투자 전략 책임자 리즈 토마스(Liz Thomas)와 함께 출연한 팟캐스트에서 기술 혁신의 초석으로 테슬라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)를 강조하고, 인공지능(AI) 투자의 미래를 옹호했다.
무슨 일 있었나: ARK 이노베이션 ETF를 이끄는 것으로 널리 알려진 캐시 우드는 테슬라를 "지구상에서 가장 큰 AI 프로젝트"라고 표현하며 여러 분야에 걸쳐 AI의 혁신적 잠재력을 강조했다.
특히 AI와 시퀀싱 기술의 융합이 혈액 검사를 통한 암 진단, 특히 크리스퍼 유전자 편집 기능과 결합될 경우 암 진단에 혁신을 가져올 수 있는 의료 분야의 발전에 주목했다.
우드는 주요 기술 기업들의 막대한 GPU 및 클라우드 인프라 투자에 대한 우려를 언급하며 자본 지출 증가에 대한 투자자들의 회의적인 시각도 인정했다.
그는 아직 명확한 수익이 입증되지 않은 투자의 예로 18개월 만에 300억 달러에서 600억 달러로 지출이 급증한 마이크로소프트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>)를 들었다.
이 기사도 읽어보세요: <a href="https://kr.benzinga.com/news/usa/stocks/%EC%BA%90%EC%8B%9C-%EC%9A%B0%EB%93%9C-%EB%B0%94%EC%9D%B4%EC%98%A4-%EB%B6%84%EC%95%BC%EC%97%90%EC%84%9C-4%EC%B2%9C%EC%96%B5-%EB%8B%AC%EB%9F%AC-%EA%B8%B0%ED%9A%8C-%EC%A0%84%EB%A7%9D/">캐시 우드, 바이오 분야에서 4천억 달러 기회 전망</a>
왜 중요한가: 캐시 우드의 이번 발언은 주력 펀드를 통해 테슬라 보유 자산을 1,800만 달러 줄이는 등 최근 포트폴리오 조정 과정 속에 나왔다. 이러한 매각에도 불구하고 우드는 "1조 달러 이상의 수익 기회"를 예상하며 테슬라의 <a href="https://www.benzinga.com/24/11/42205945/ark-invests-bold-move-tesla-shares-sold-amid-market-shifts" target="_blank" rel="noopener">자율주행 잠재력</a>에 대해 낙관적인 장기 전망을 유지하고 있다.
우드의 투자 논리는 테슬라를 넘어 광범위한 생물학 분야로 확장되어 AI, 유전자 염기서열 분석, <a href="https://www.benzinga.com/general/biotech/24/11/42206182/cathie-wood-sees-400b-opportunity-in-biologics-how-have-her-bets-fared" target="_blank" rel="noopener">유전자 편집 기술</a>의 융합으로 4,000억 달러의 시장 기회가 창출될 것으로 예상하고 있다.
11억 7,900만 달러의 자산을 운용하는 ARK Genomic Revolution ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>)는 이러한 신념을 반영하여 트위스트 바이오사이언스 코퍼레이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWST#NASDAQ">TWST</a>), CRISPR 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>) 같은 회사에 상당한 투자를 단행했다.
우드는 시장 밸류에이션 상승에 대한 우려에 대해 현재 20대 초반의 시장 멀티플은 오류의 여지가 거의 없다고 지적했다. 그러나 특히 AI와 의료 혁신의 교차점에서 <a href="https://www.benzinga.com/general/biotech/24/11/42206182/cathie-wood-sees-400b-opportunity-in-biologics-how-have-her-bets-fared" target="_blank" rel="noopener">질병 치료 및 진단</a>의 혁신적인 발전 가능성을 보는 비즈니스 모델의 출현에 대해 여전히 확신을 가지고 있다.
이미지 출처: 아크 인베스트
면책 조항: 이 기사는 부분적으로 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>의 도움으로 작성되었으며 Benzinga 편집자가 검토 후 게시했습니다.
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Global

TWST

캐시 우드 "테슬라는 지구상에서 가장 큰 AI 프로젝트", 기술 투자에 대해 우려하지 않아

아크 인베스트의 CEO인 캐시 우드는 인공지능, 유전자 염기서열(시퀀싱) 분석, 유전자 편집 기술의 교차점에서 전례 없는 잠재력을 발견하고 바이오 분야에 투자를 강화하고 있다.
무슨 일 있었나: 캐시 우드의 열정은 의료와 신약 개발에 혁명을 일으킬 수 있는 혁신적인 기술 융합에 집중되어 있다.
그는 이 분야에 대해 솔직하게 이야기하면서 특히 크리스퍼 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>), 인텔리아 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>), 빔 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>) 같은 회사에서 유전자 치료의 괄목할 만한 발전이 이루어지고 있다고 강조했다.
가장 눈에 띄는 사례는 최근 크리스퍼 테라퓨틱스가 겸상 적혈구 질환 치료 분야에서 거둔 획기적인 성과다. 우드는 이전에는 연간 12~20회 수혈을 받아야 했던 환자들이 이제 그런 수혈을 받지 않아도 될 수 있게 되었다고 언급했다.
이러한 전략은 치료의 혁신을 넘어 신약 개발 자체로 확장횐다. 우드는 리커전 파마슈티컬스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>)와 같은 회사가 인공지능을 활용하여 임상시험 실패율을 획기적으로 줄이고 신약 개발 일정을 앞당기고 있다고 강조했다.
그러나 이러한 혁신적인 기업들의 시장 성과는 좀 더 복잡한 이야기를 담고 있다. 올해 들어 이들 주식은 상당한 변동성을 보였다. <a href="//www.benzinga.com/pro/"" target="_blank" rel="noopener">벤징가 프로 데이터</a>에 따르면 연초 대비 크리스퍼 테라퓨틱스는 25.36% 하락, 인텔리아 테라퓨틱스는 52.21% 하락, 빔 테라퓨틱스는 3.04% 하락, 리커션 제약은 9.80% 하락했다.
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Which market sector excites <a href="https://twitter.com/CathieDWood?ref_src=twsrc%5Etfw">@CathieDWood</a> the most and why? In <a href="https://twitter.com/hashtag/askARK?src=hash&amp;ref_src=twsrc%5Etfw">#askARK</a>, she shares her growing enthusiasm for the biologics space.
Have more questions for Cathie? Share them in the comments. <a href="https://t.co/WjilZChce6">pic.twitter.com/WjilZChce6</a>
&mdash; ARK Invest (@ARKInvest) <a href="https://twitter.com/ARKInvest/status/1861431767506268404?ref_src=twsrc%5Etfw">November 26, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
이 기사도 읽어보세요: <a href="https://kr.benzinga.com/news/usa/stocks/%EC%BA%90%EC%8B%9C-%EC%9A%B0%EB%93%9C%EC%9D%98-%EC%95%84%ED%81%AC-%EC%9D%B8%EB%B2%A0%EC%8A%A4%ED%8A%B8-%ED%85%8C%EC%8A%AC%EB%9D%BC-%EC%A3%BC%EC%8B%9D-1800%EB%A7%8C-%EB%8B%AC%EB%9F%AC-%EC%83%81/" target="_blank" rel="noopener">캐시 우드의 아크 인베스트, 테슬라 주식 1,800만 달러 상당 매각</a>
왜 중요한가: 바이오 분야에 대한 아크 인베스트의 노력은 11억 7,900만 달러의 순자산을 관리하는 Genomic Revolution ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>)를 통해 분명하게 드러난다. 이 펀드의 성과는 2020년 최고 180.50%에서 2022년 최저 -53.94%에 이르는 연간 수익률로 해당 섹터의 변동성을 반영하고 있다.
이 ETF의 현재 상위 보유 종목은 혁신적인 바이오 기술에 대한 캐시 우드의 전략적 초점을 강조한다. 트위스트 바이오사이언스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWST#NASDAQ">TWST</a>)가 8.90%의 비중으로 포트폴리오를 이끌고 있으며, 크리스퍼 테라퓨틱스가 7.88%, 리커션 파마슈티컬스가 6.17%로 그 뒤를 잇고 있다. 그 밖의 주요 투자 기업으로는 케어DX(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNA#NASDAQ">CDNA</a>), 베라사이트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCYT#NASDAQ">VCYT</a>), 어댑티브 바이오테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADPT#NASDAQ">ADPT</a>) 등이 있으며, 이들은 게놈 및 생물학적 혁신에 대한 다양한 접근 방식을 대표한다.
캐시 우드는 AI, 시퀀싱 기술, 유전자 편집의 전례 없는 융합 덕분에 향후 5년 동안 바이오 분야에서 4,000억 달러의 시장 기회가 있을 것으로 전망한다.
이미지 출처: Ark Invest
면책 조항: 이 콘텐츠는 부분적으로 AI 도구의 도움을 받아 생성되었으며, Benzinga 편집자가 검토 후 게시했습니다.
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

ADPT

CDNA

VCYT

캐시 우드, 바이오 분야에서 4천억 달러 기회 전망

캐시 우드가 이끄는 아크 펀드(Ark Funds)는 미래 성장 <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41593922/cathie-woods-ark-invest-sees-tesla-unlocking-11-trillion-revenue-potential-with-rob" target="_blank" rel="noopener" data-google-interstitial="false">혁신 분야</a>에 중점을 두고 적극적으로 관리되는 ETF들 덕분에 가장 잘 알려진 펀드 매니저 중 하나이다.
이 펀드의 ETF 두 개가 목요일에 10주년을 맞이했다. 이들 펀드의 출시와 지난 10년 동안의 성과를 살펴보겠다.
아크 이노베이션: 우드와 <a href="https://www.benzinga.com/topic/ark-funds">아크 펀드</a>는 Ark Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)를 2014년 10월 31일에 출시했다. 이 펀드는 이 회사의 가장 유명하고 가장 큰 펀드로 성장했으며, 현재 57억 8천만 달러의 운용 자산을 보유하고 있다.
&#8220;ARRK는 자본의 장기적 성장을 추구하는 액티브하게 관리되는 ETF로, 일반적으로 국내 및 해외 주식에 주로 투자하여 펀드의 투자 테마인 파괴적 혁신(disruptive innovation)와 관련된 회사들에 투자한다&#8221;고 이 회사의 <a href="https://www.ark-funds.com/funds/arkk">웹사이트</a>에서 설명한다.
파괴적 혁신 테마에는 자율 이동성, 정밀 치료, 차세대 클라우드, 신경망, 지능형 기기, 디지털 지갑, 디지털 자산, 스마트 계약 및 멀티오믹 기술이 포함된다.
&#8220;ARK는 &#8216;파괴적 혁신&#8217;을 세상이 돌아가는 방식에 잠재적으로 도전할 수 있는 기술적으로 구현된 새로운 제품이나 서비스의 도입으로 정의한다.&#8221;
현재 ARKK ETF의 상위 10개 보유 종목과 그 순자산 비율은 다음과 같다:
<ol>
<li>테슬라 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>): 14.1%</li>
<li>로쿠 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>): 10.8%</li>
<li>코인베이스 글로벌 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>): 8.1%</li>
<li>로블록스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>): 6.2%</li>
<li>팔란티어 테크놀로지스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>): 5.1%</li>
<li>로빈후드 마켓 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>): 5.0%</li>
<li>블록 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>): 4.9%</li>
<li>크리스퍼 테라퓨틱스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>): 4.5%</li>
<li>쇼피파이 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>): 3.9%</li>
<li>유아이패스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>): 2.9%</li>
</ol>
이 펀드 설립 이래로 이 ETF의 수익률은 161.4% 상승했다. 이 수익률은 S&amp;P 500을 추적하는 SPDR S&amp;P 500 ETF Trust(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)의 현재 10년 수익률에는 미치지 못한다.
아래의 표는 ARKK의 수익률이 SPY와 어떻게 비교되는지를 보여준다. SPY는 <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/10/41407647/spy-reaches-600-billion-in-assets-oldest-us-ETF-hits-milestone-as-all-time-highs-conti">가장 오래되고 가장 큰</a> 미국 ETF이다:
<figure class="wp-block-table">
<table style="overflow:auto; height: 90px; display: block;">
<tbody>
<tr>
<td>평균 연간 수익률</td>
<td>ARKK</td>
<td>SPY</td>
</tr>
<tr>
<td>1년</td>
<td>+19.9%</td>
<td>+36.2%</td>
</tr>
<tr>
<td>3년</td>
<td>-24.3%</td>
<td>+11.8%</td>
</tr>
<tr>
<td>5년</td>
<td>+2.6%</td>
<td>+15.8%</td>
</tr>
<tr>
<td>ARKK 설립 이래 2014년 10월 31일 기준</td>
<td>+10.2%</td>
<td>+13.2%</td>
</tr>
</tbody>
</table>
</figure>
아래의 차트는 <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent103124&amp;t=be2bearmibe3na1">Benzinga Pro</a>에서 제공한 ARKK의 10년 수익률을 보여준다.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent103124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" class="wp-image-624517" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/31133929/Screenshot-224.png" sizes="(max-width: 1003px) 100vw, 1003px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/31133929/Screenshot-224.png 1003w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/31133929/Screenshot-224-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/31133929/Screenshot-224-768x393.png 768w" alt="" width="1003" height="513" /></a></figure>
비교를 위해 SPY의 10년 차트도 보여드리겠다.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent103124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" class="wp-image-624522" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/31134001/Screenshot-226.png" sizes="(max-width: 995px) 100vw, 995px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/31134001/Screenshot-226.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/31134001/Screenshot-226-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/31134001/Screenshot-226-768x392.png 768w" alt="" width="995" height="508" /></a></figure>
다음 읽어보기: <a href="https://www.benzinga.com/markets/penny-stocks/23/08/34102486/exclusive-cathie-wood-tells-benzinga-why-tesla-should-trade-as-a-tech-stock">독점: 캐시 우드가 테슬라가 기술 주식으로 거래되어야 하는 이유를 Benzinga에 말했다.</a>
아크 지노믹스: Ark Genomic Revolution ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>)는 2014년 10월 31일에 아크 펀드에 의해 출시되었다. 현재 이 ETF 펀드는 13억 3천만 달러의 자산을 운용하고 있다.
&#8220;ARKG는 자본의 장기적 성장을 추구하는 액티브하게 관리되는 ETF로, 일반적으로 헬스 케어, 정보 기술, 소재, 에너지 및 소비재 등 여러 섹터의 국내외 주식에 주로 투자하며, 펀드의 투자 테마인 유전체 혁명(genomics revolution)과 관련된 회사들에 투자한다&#8221;고 이 회사의 <a href="https://www.ark-funds.com/funds/arkg">웹사이트</a>에서 설명한다.
이 유전체 혁명 ETF의 테마에는 정밀 치료, 멀티오믹 기술, 프로그래머블 생물학, 신경망, 차세대 클라우드 및 적응형 로보틱스가 포함된다.
현재 ARKG ETF의 상위 10개 보유 종목과 그 순자산 비율은 다음과 같다:
<ol>
<li>트위스트 바이오사이언스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWST#NASDAQ">TWST</a>): 8.7%</li>
<li>리커젼 파마슈티컬스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>): 7.0%</li>
<li>크리스퍼 테라퓨틱스: 7.0%</li>
<li>케어Dx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNA#NASDAQ">CDNA</a>): 5.1%</li>
<li>어댑티브 바이오테크놀로지스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADPT#NASDAQ">ADPT</a>): 4.7%</li>
<li>베라사이트 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VYCT#NASDAQ">VYCT</a>): 4.6%</li>
<li>아이오니스 파마슈티컬스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONS#NASDAQ">IONS</a>): 4.3%</li>
<li>누릭스 테라퓨틱스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRIX#NASDAQ">NRIX</a>): 4.1%</li>
<li>나테라 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRA#NASDAQ">NTRA</a>): 3.8%</li>
<li>10x 지노믹스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXG#NASDAQ">TXG</a>): 3.8%</li>
</ol>
이 펀드 설립 이래로 이 ETF의 수익률은 38.9% 상승했다. 이 수익률은 현재 SPDR S&amp;P 500 ETF Trust의 10년 수익률에는 미치지 못한다.
ARKG의 수익률이 SPY와 어떻게 비교되는지를 살펴보겠다.
<figure class="wp-block-table">
<table style="overflow:auto; height: 90px; display: block;">
<tbody>
<tr>
<td>평균 연간 수익률</td>
<td>ARKG</td>
<td>SPY</td>
</tr>
<tr>
<td>1년</td>
<td>-7.9%</td>
<td>+36.2%</td>
</tr>
<tr>
<td>3년</td>
<td>-29.9%</td>
<td>+11.8%</td>
</tr>
<tr>
<td>5년</td>
<td>-1.9%</td>
<td>+15.8%</td>
</tr>
<tr>
<td>ARKG 설립 이래 2014년 10월 31일 기준</td>
<td>+3.3%</td>
<td>+13.2%</td>
</tr>
</tbody>
</table>
</figure>
다음은 ARKG의 10년 차트다.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent103124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" class="wp-image-624525" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/31134031/Screenshot-225.png" sizes="(max-width: 993px) 100vw, 993px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/31134031/Screenshot-225.png 993w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/31134031/Screenshot-225-300x154.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/31134031/Screenshot-225-768x394.png 768w" alt="" width="993" height="510" /></a></figure>
중요성 (Why It&#8217;s Important): 위의 차트들은 ARKK와 ARKG가 모두 투자자들에게 몇 년 동안 강력한 성장과 수익률을 경험했지만, 최근 몇 년 동안은 더 넓은 S&amp;P 500 시장 지수를 하회한 것을 보여준다.
한때 이 ETF들은 가장 화제가 된 펀드들 중 하나였으며, 이 회사의 일일 거래 활동은 종종 주식을 상승시켰다. 이는 우드의 뛰어난 성과 덕분이다.
S&amp;P 500 ETF는 분기마다 리밸런싱을 하지만, 이 액티브하게 관리되는 펀드는 거의 매일 거래를 완료한다. 종종 주가가 상승하는 주식의 평균 매입가가 시간이 지남에 따라 상승하여 수익률에 부정적인 영향을 미칠 수 있다.
아크 펀드는 일반적으로 향후 5년에서 10년 동안 강력한 성장을 할 것으로 믿는 회사들에 투자한다. 이는 펀드의 수익률이 때때로 몇 년이 걸려야 나타날 수 있음을 의미한다.
우드는 엔비디아의 주식을 2014년에 약 5달러에 매수한 것과 같이 많은 테마에 대해 일찍 투자한 바 있다. 이는 가장 최근의 주식 분할 이전의 일이었다. 이 펀드는 나중에 2022년 말과 2023년 초에 이 포지션에서 완전히 매도하여 지난 2년 가까이 <a style="font-size: revert;" href="https://www.benzinga.com/general/education/24/02/37294405/heres-how-much-cathie-wood-ark-invest-flagship-fund-missed-by-selling-nvidia-early">엄청난 수익을 놓쳤</a>다.
이 펀드 매니저는 또한 테슬라 성장 스토리에 일찍 투자했다. 2018년 2월에 이 전기차 회사에 대해 $4,000 목표 주가를 <a href="https://www.benzinga.com/news/22/03/26046331/if-you-invested-1-000-in-tesla-when-cathie-wood-made-her-4-000-prediction-heres-how-much-youd-have-n-1" target="_blank" rel="noopener">예측</a>했다. 당시에는 가격 예측으로 비웃음거리가 되었지만, 주가는 2021년 1월에 분할 기준으로 목표 주가에 도달했다.
테슬라에 대한 예측이 맞아들어간 것은 우드의 펀드 매니저로서의 위상을 높이는 데 도움이 되었고, 아크 펀드 ETF들에 대한 관심이 증가하는 계기가 되었다.
최근 몇 년 동안 아크 펀드 ETF들에 대한 관심이 식었지만, 많은 투자자들은 여전히 그들의 영향을 기억하고 일일 거래 활동을 계속 추적하며, 우드가 향후 5년에서 10년 동안 보유할 주식을 주의 깊게 지켜보고 있다.

다음 읽어보기:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/23/08/34028505/exclusive-why-does-cathie-wood-think-bitcoin-is-going-to-1-million-what-does-she-know-that">독점: 캐시 우드는 왜 비트코인이 100만 달러에 이를 것이라고 생각하는가? 그녀는 무엇을 알고 있기에?</a></li>
</ul>
이미지 제공: Ark Invest 및 Shutterstock.
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

CRISPR Therapeutics

뉴스

에 대한 최신 뉴스 CRISPR Therapeutics (NASDAQ:CRSP) 주식

토요일, 4월 05, 2025

수요일, 3월 12, 2025

일요일, 2월 16, 2025

토요일, 2월 01, 2025

수요일, 1월 22, 2025

일요일, 1월 19, 2025

금요일, 11월 29, 2024

수요일, 11월 27, 2024

금요일, 11월 01, 2024

뉴스

파트너 / 기고자

벤징가 글로벌